Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Wucao Anfu Formula as Adjunctive Treatment for Immune Checkpoint Inhibitor-Related Rash

NCT07821424 is registered in ClinicalTrials.gov with First Teaching Hospital of Tianjin University of Traditional Chinese Medicine as lead sponsor.

NCT NCT07821424
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07821424 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Wucao Anfu Formula as Adjunctive Treatment for Immune Checkpoint Inhibitor-Related Rash
Lead sponsor
First Teaching Hospital of Tianjin University of Traditional Chinese Medicine
Phase
Not applicable
Overall status
Not yet recruiting
Start date
September 5, 2026
Completion date
June 30, 2027
Enrollment
72 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

immune checkpoint inhibitor-related rash, immune-related adverse events